Alpers syndrome with prominent white matter changes.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Brain & development (Tokyo. 1979)

• Publication date

  2008-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.BRAINDEV.2007.08.009PMID 17923349
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multiple oxidative phosphorylation deficiencies in severe childhood multi-system disorders due to polymerase gamma (POLG1) mutations

  2007cited by this paper
• Mutations in the MPV17 gene are responsible for rapidly progressive liver failure in infancy

  2007cited by this paper
• Molecular diagnosis of Alpers syndrome.

  2006cited by this paper
• POLG1 Mutations Associated With Progressive Encephalopathy in Childhood

  2006cited by this paper
• Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene.

  2006cited by this paper
• The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases.

  2006cited by this paper
• A polymorphic polymerase.

  2006cited by this paper
• Phenotypic spectrum associated with mutations of the mitochondrial polymerase γ gene. Commentary

  2006cited by this paper
• POLG mutations and Alpers syndrome

  2005cited by this paper
• Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA polymerase-gammaA.

  2005cited by this paper
• Consequences of mutations in human DNA polymerase γ

  2005cited by this paper
• The Common A467T Mutation in the Human Mitochondrial DNA Polymerase (POLG) Compromises Catalytic Efficiency and Interaction with the Accessory Subunit*

  2005cited by this paper
• Simultaneous detection and quantification of mitochondrial DNA deletion(s), depletion, and over-replication in patients with mitochondrial disease.

  2005cited by this paper
• Consequences of mutations in human DNA polymerase gamma.

  2005cited by this paper
• POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion

  2004cited by this paper
• Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study.

  2004cited by this paper
• Progressive neuronal degeneration of childhood with liver disease

  2004cited by this paper
• POLG mutations in neurodegenerative disorders with ataxia but no muscle involvement

  2004cited by this paper
• Central-peripheral sensory axonopathy in a juvenile case of Alpers-Huttenlocher disease

  2003cited by this paper
• Recessive POLG mutations presenting with sensory and ataxic neuropathy in compound heterozygote patients with progressive external ophthalmoplegia.

  2003cited by this paper
• Mutations of mitochondrial DNA polymerase γA are a frequent cause of autosomal dominant or recessive progressive external ophthalmoplegia

  2002cited by this paper
• Mitochondrial DNA polymerase γ deficiency and mtDNA depletion in a child with Alpers' syndrome

  1999cited by this paper
• Mitochondrial DNA polymerase gamma deficiency and mtDNA depletion in a child with Alpers' syndrome.

  1999cited by this paper
• Yield of mtDNA mutation analysis in 2,000 patients.

  1998cited by this paper
• Direct detection of multiple point mutations in mitochondrial DNA.

  1997cited by this paper
• Progressive neuronal degeneration of childhood with liver disease (Alpers' disease) presenting in young adults.

  1995cited by this paper
• Review Article: Progressive Neuronal Degeneration of Childhood With Liver Disease (Alpers-Huttenlocher Syndrome): A Personal Review

  1990cited by this paper
• Infantile diffuse cerebral degeneration with hepatic cirrhosis.

  1976cited by this paper

• Primary mitochondrial diseases.

  2024cites this paper
• Molecular Mimicry between Meningococcal B Factor H-Binding Protein and Human Proteins

  2023cites this paper
• Mitochondrial Neurodegenerative Disorders II: Ataxia, Dystonia and Leukodystrophies

  2019cites this paper
• Severe hepatopathy and neurological deterioration after start of valproate treatment in a 6-year-old child with mitochondrial tryptophanyl-tRNA synthetase deficiency

  2018cites this paper
• The role of POLG mutations in human disease

  2018cites this paper
• Electro-clinical-etiological associations of epilepsia partialis continua in 57 Chinese children.

  2017cites this paper
• Epilepsy due to mutations in the mitochondrial polymerase gamma (POLG) gene: A clinical and molecular genetic review

  2016cites this paper
• Myocerebrohepatopathy spectrum disorder due to POLG mutations: A clinicopathological report.

  2015cites this paper
• Magnetic resonance imaging correlates of genetically characterized patients with mitochondrial disorders: A study from south India.

  2015cites this paper
• The 3-methylglutaconic acidurias revisited

  2013cites this paper
• Adverse drug reactions induced by valproic acid.

  2013cites this paper
• Early muscle and brain ultrastructural changes in polymerase gamma 1‐related encephalomyopathy

  2013cites this paper
• Mitochondrial Syndromes with Leukoencephalopathies

  2012cites this paper
• Degenerative Disorders Primarily of Gray Matter

  2012cites this paper
• Genetic and Metabolic Disorders of the White Matter

  2012cites this paper
• Palliative functional hemispherectomy for treatment of refractory status epilepticus associated with Alpers' disease

  2011cites this paper
• POLG DNA testing as an emerging standard of care before instituting valproic acid therapy for pediatric seizure disorders.

  2010cites this paper
• Status epilepticus in children with Alpers’ disease caused by POLG1 mutations: EEG and MRI features

  2009cites this paper
• Pay Attention to Late Onset Childhood Epilepsy due to Inborn Errors of Metabolism

  2008cites this paper
• Molecular and clinical genetics of mitochondrial diseases due to POLG mutations

  2008cites this paper